James F List

Summary

Affiliation: Bristol-Myers Squibb
Country: USA

Publications

  1. pmc Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes
    James F List
    Global Clinical Research, Bristol Myers Squibb, Princeton, New Jersey, USA
    Diabetes Care 32:650-7. 2009
  2. pmc Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
    Clifford J Bailey
    Life and Health Sciences, Aston University, Birmingham B4 7ET, UK
    BMC Med 11:43. 2013

Collaborators

  • Clifford J Bailey
  • Nayyar Iqbal
  • Delphine Hennicken
  • Jorge L Gross
  • Traci A Mansfield

Detail Information

Publications2

  1. pmc Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes
    James F List
    Global Clinical Research, Bristol Myers Squibb, Princeton, New Jersey, USA
    Diabetes Care 32:650-7. 2009
    ..In this multiple-dose study we evaluated the safety and efficacy of dapagliflozin in type 2 diabetic patients...
  2. pmc Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
    Clifford J Bailey
    Life and Health Sciences, Aston University, Birmingham B4 7ET, UK
    BMC Med 11:43. 2013
    ..The present study is an extension that was undertaken to evaluate dapagliflozin as long-term therapy in this population...